Sarma M, Saha D, Das B, Das T, Azizov S, Kumar D
Naunyn Schmiedebergs Arch Pharmacol. 2023; 396(10):2217-2240.
PMID: 37099165
DOI: 10.1007/s00210-023-02496-4.
Zaky A, Kandeil M, Abdel-Gabbar M, Fahmy E, Almehmadi M, Ali T
Pharmaceutics. 2022; 14(2).
PMID: 35213996
PMC: 8876146.
DOI: 10.3390/pharmaceutics14020263.
Amare Y
Evid Based Complement Alternat Med. 2022; 2021:3987656.
PMID: 35003299
PMC: 8731287.
DOI: 10.1155/2021/3987656.
Ali A, Gabbar M, Abdel-Twab S, Fahmy E, Ebaid H, Alhazza I
Oxid Med Cell Longev. 2020; 2020:1730492.
PMID: 32655759
PMC: 7327566.
DOI: 10.1155/2020/1730492.
Bin-Jumah M
Oxid Med Cell Longev. 2019; 2019:6290143.
PMID: 30915195
PMC: 6399546.
DOI: 10.1155/2019/6290143.
Pharmacological evaluation of "sugar remedy," a polyherbal formulation, on streptozotocin-induced diabetic mellitus in rats.
Singhal S, Rathore A, Lohar V, Dave R, Dave J
J Tradit Complement Med. 2014; 4(3):189-95.
PMID: 25161924
PMC: 4142457.
DOI: 10.4103/2225-4110.127800.
Paederia foetida Linn. leaf extract: an antihyperlipidemic, antihyperglycaemic and antioxidant activity.
Kumar V, Anwar F, Ahmed D, Verma A, Ahmed A, Damanhouri Z
BMC Complement Altern Med. 2014; 14:76.
PMID: 24564866
PMC: 3936833.
DOI: 10.1186/1472-6882-14-76.
Enhanced glycemic control, pancreas protective, antioxidant and hepatoprotective effects by umbelliferon-α-D-glucopyranosyl-(2(I) → 1(II))-α-D-glucopyranoside in streptozotocin induced diabetic rats.
Kumar V, Ahmed D, Anwar F, Ali M, Mujeeb M
Springerplus. 2013; 2:639.
PMID: 24349947
PMC: 3862866.
DOI: 10.1186/2193-1801-2-639.
Umbelliferone β-D-galactopyranoside from Aegle marmelos (L.) corr. an ethnomedicinal plant with antidiabetic, antihyperlipidemic and antioxidative activity.
Kumar V, Ahmed D, Verma A, Anwar F, Ali M, Mujeeb M
BMC Complement Altern Med. 2013; 13:273.
PMID: 24138888
PMC: 3833852.
DOI: 10.1186/1472-6882-13-273.
Anti-diabetic, anti-oxidant and anti-hyperlipidemic activities of Melastoma malabathricum Linn. leaves in streptozotocin induced diabetic rats.
Kumar V, Ahmed D, Gupta P, Anwar F, Mujeeb M
BMC Complement Altern Med. 2013; 13:222.
PMID: 24010894
PMC: 3847142.
DOI: 10.1186/1472-6882-13-222.
Improved glycemic control, pancreas protective and hepatoprotective effect by traditional poly-herbal formulation "Qurs Tabasheer" in streptozotocin induced diabetic rats.
Ahmed D, Sharma M, Mukerjee A, Ramteke P, Kumar V
BMC Complement Altern Med. 2013; 13:10.
PMID: 23305114
PMC: 3564698.
DOI: 10.1186/1472-6882-13-10.
Hepatic steatosis in type 1 diabetes.
Regnell S, Lernmark A
Rev Diabet Stud. 2012; 8(4):454-67.
PMID: 22580727
PMC: 3359690.
DOI: 10.1900/RDS.2011.8.454.
Pharmacological evaluation of "Glyoherb": A polyherbal formulation on streptozotocin-induced diabetic rats.
Thakkar N, Patel J
Int J Diabetes Dev Ctries. 2010; 30(1):1-7.
PMID: 20431798
PMC: 2859276.
DOI: 10.4103/0973-3930.60001.
Glycogen synthase in diabetic rat skeletal muscle: activation by insulin.
Komuniecki P, Kochan R, Schlender K, Reimann E
Mol Cell Biochem. 1982; 48(3):129-34.
PMID: 6817078
DOI: 10.1007/BF00421224.
Effects of glucose on phosphorylase and glycogen synthase in hepatocytes from diabetic rats.
Bollen M, Hue L, Stalmans W
Biochem J. 1983; 210(3):783-7.
PMID: 6409078
PMC: 1154290.
DOI: 10.1042/bj2100783.
Hepatic effects of glucose and insulin independent of cyclic nucleotide changes.
Davidson M, Yoshii V
Acta Diabetol Lat. 1981; 18(4):297-310.
PMID: 6277120
DOI: 10.1007/BF02042813.
Metabolic adaptation in muscle of phosphorylase deficiency (McArdle's disease)?.
Nolte J, Schollmeyer P
Klin Wochenschr. 1973; 51(5):250-1.
PMID: 4511939
DOI: 10.1007/BF01467777.
Changes in the activity of enzymes, participating in glycogen metabolism of alloxan diabetic rats.
Parsadanian H, Ter-Tatevosian L, Martikian H, Avakian S
Mol Cell Biochem. 1989; 90(2):185-90.
PMID: 2555679
DOI: 10.1007/BF00221218.
Effect of insulin on ultrastructure and glycogenesis in primary cultures of adult rat hepatocytes.
Bernaert D, Wanson J, DROCHMANS P, Popowski A
J Cell Biol. 1977; 74(3):878-900.
PMID: 409722
PMC: 2110106.
DOI: 10.1083/jcb.74.3.878.
Characterization and regulation of reductase kinase, a protein kinase that modulates the enzymic activity of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
Beg Z, Stonik J, BREWER Jr H
Proc Natl Acad Sci U S A. 1979; 76(9):4375-9.
PMID: 291971
PMC: 411577.
DOI: 10.1073/pnas.76.9.4375.
